Healthcare -
Biotechnology - NASDAQ - US
$ 3.65
-12.7 %
$ 126 M
Market Cap
-3.88
P/E
GNLX - OTHER CURRENT ASSETS
Other Current Assets GNLX - Genelux Corporation
1.01 M
LAST VALUE
-12.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR